...
首页> 外文期刊>Hypertension research: Official journal of the Japanese Society of Hypertension >Effects of angiotensin II receptor antagonists on insulin resistance syndrome and leptin in sucrose-fed spontaneously hypertensive rats.
【24h】

Effects of angiotensin II receptor antagonists on insulin resistance syndrome and leptin in sucrose-fed spontaneously hypertensive rats.

机译:血管紧张素II受体拮抗剂对蔗糖喂养的自发性高血压大鼠胰岛素抵抗综合征和瘦素的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In order to investigate the usefulness of angiotensin II type 1 receptor (AT1) antagonists (ARA) in the treatment of hypertension with insulin resistance syndrome, we studied the effects of a high dose sucrose diet and ARA on insulin sensitivity, plasma lipids, and leptin in spontaneous hypertensive rats (SHR) and Wistar-Kyoto rats (WKY). SHR and WKY were divided into three groups and treated for 12 weeks: those fed a standard chow, those given a sucrose-rich chow or those given a sucrose-rich chow and ARA. While in SHR the weight of both subcutaneous and mesenteric adipose tissue was greater in the sucrose-rich chow fed animals than in the standard chow fed animals, ARA treatment significantly decreased the weights of both subcutaneous and mesenteric adipose tissue. ARA treatment decreased free fatty acid and triglyceride in SHR, and increased high density lipoprotein cholesterol in SHR and WKY. Homeostasis model assessment-insulin resistance (HOMA-IR) index, plasma levels of leptin, and leptin mRNA in mesenteric adipose tissue were significantly greater in the sucrose-rich chow fed animals than in the standard chow fed animals, and significantly lower in the ARA-treated sucrose-rich chow fed animals than in the sucrose-rich chow fed animals in both SHR and WKY. ARA improved insulin resistance, and reduced plasma leptin and leptin mRNA in adipose tissue. These results suggest that the improvement of insulin resistance by ARA may be attributed, at least in part, to the reduction of adipose tissue weight. It is concluded that ARA is useful in the treatment of patients with hypertension and concomitant insulin resistance syndrome.
机译:为了研究血管紧张素II 1型受体(AT1)拮抗剂(ARA)在治疗患有胰岛素抵抗综合征的高血压中的作用,我们研究了高剂量蔗糖饮食和ARA对胰岛素敏感性,血浆脂质和瘦素的影响在自发性高血压大鼠(SHR)和Wistar-Kyoto大鼠(WKY)中。 SHR和WKY分为三组并治疗12周:那些喂了标准的食物,那些吃了蔗糖的食物或那些吃了蔗糖的食物和ARA。尽管在SHR中,富含蔗糖的食物喂养的动物的皮下和肠系膜脂肪组织的重量都比标准食物喂养的动物大,但ARA处理显着降低了皮下和肠系膜脂肪组织的重量。 ARA治疗可减少SHR中的游离脂肪酸和甘油三酸酯,并增加SHR和WKY中的高密度脂蛋白胆固醇。富含蔗糖的cho饲动物的体内稳态模型评估胰岛素抵抗(HOMA-IR)指数,血浆中瘦素水平和瘦素mRNA的水平显着高于标准cho饲动物,而ARA显着降低-在SHR和WKY中,用富含蔗糖的食物喂养的动物比用富含蔗糖的食物喂养的动物。 ARA可改善胰岛素抵抗,并减少脂肪组织中的血浆瘦素和瘦素mRNA。这些结果表明,ARA对胰岛素抵抗的改善可能至少部分归因于脂肪组织重量的减少。结论是,ARA可用于治疗高血压和伴随胰岛素抵抗综合征的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号